GENE ONLINE|News &
Opinion
Blog

2025-05-10|

Roche Invests $50 Billion in U.S., Creating Over 12,000 Jobs

by Mark Chiang
Share To

Roche, a Swiss multinational healthcare company, will invest $50 billion in the United States over the next five years. The investment will create more than 12,000 jobs, which includes nearly 6,500 construction jobs, and 1,000 positions at new and expanded facilities. The company’s investments will add to Roche’s existing infrastructure in the U.S., where it currently has 13 manufacturing and 15 research and development sites across its pharmaceutical and diagnostics divisions. These expansions and new facilities are poised to significantly bolster Roche’s presence and operations within the United States.

Newsflash | Powered by GeneOnline AI
Date: May 8, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
LATEST
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
NIH Restores Research Funding to Previously Defunded Scientists Amid Policy Shifts
2025-05-20
Prime Medicine Reduces Workforce by 25 Percent and Appoints David Schenkein as New CEO
2025-05-20
UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates
2025-05-20
Trump Science Adviser Michael Kratsios Calls for Renewed Focus on Reproducible Research Practices to Address Scientific Stagnation
2025-05-20
House Republicans Propose $700 Billion Medicaid Savings with Work Requirements
2025-05-20
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top